Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.270
-0.040 (-3.05%)
At close: Mar 30, 2026, 4:00 PM EDT
1.270
0.00 (0.00%)
After-hours: Mar 30, 2026, 4:10 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $79.8 million as of March 30, 2026. Its market cap has increased by 25.41% in one year.
Market Cap
79.80M
Enterprise Value
31.61M
1-Year Change
25.41%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $79.80M, a decrease of -84.76%. That is a compound annual growth rate of -34.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 82.31M | 14.95% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 86.28M |
| Fortress Biotech | 85.66M |
| Anixa Biosciences | 85.50M |
| LeonaBio | 83.74M |
| Kazia Therapeutics | 81.82M |
| PolyPid | 81.68M |
| Gossamer Bio | 81.32M |
| Rani Therapeutics Holdings | 80.83M |